603456 九洲药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,342,005991,6551,360,3241,225,782677,519
投资活动产生之现金流量净额(528,637)(881,326)(1,056,803)(738,417)(765,438)
筹资活动产生之现金流量净额(835,569)(609,611)2,102,185(608,963)582,429
汇率变动对现金及现金等价物的影响(4,113)16,8957,60557,611(22,591)
现金及现金等价物净增加/(减少)(26,314)(482,387)2,413,311(63,987)471,920
期初现金及现金等价物余额2,593,6823,076,069662,759726,746254,826
期末现金及现金等价物余额2,567,3682,593,6823,076,069662,759726,746